arrow
V

Vimal K. Derebail

University of North Carolina at Chapel Hill
H指数:39
被引数:5,000

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Multicenter, Open-Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST)

一项多中心、开放标签、II期临床试验,比较克瑞扎尼鲁单抗联合标准疗法与单独标准疗法对镰状细胞肾病患者的肾功能影响(STEADFAST)

2026-07-280
OAAI
Antimicrobial Prophylaxis in US Medicare Beneficiaries Receiving Immunosuppressants for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

抗微生物预防在美国使用免疫抑制剂治疗抗中性粒细胞胞浆抗体相关血管炎的医疗保险受益者中的应用

2025-12-110
OAAI
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome [Kidney International Reports (vol 9, pg 3053, 2024)

《抗凝治疗预防肾病综合征中的血栓事件》 [Kidney International Reports (vol 9, pg 3053, 2024)]

2025-01-010
OAAI
Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model

利用小鼠模型探讨镰状细胞特质中静脉血栓形成和慢性肾脏疾病的病理生理机制

2025-01-010
OA
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
2024-06-0111
OAAI
Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy
2023-04-015
OAAI